Bombay Dyeing Manufacturing Company Ltd vs Skybiotech Healthcare Limited Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 28, 2026

Key Highlights

The Latest Trading Price of Bombay Dyeing & Manufacturing Company Ltd is ₹ 131.5 as of 25 Jun 15:30 . The P/E Ratio of Bombay Dyeing & Manufacturing Company Ltd changed from 1.1 on March 2024 to 5.5 on March 2025 . This represents a CAGR of 123.61% over 2 yearsThe P/E Ratio of Skybiotech Healthcare Limited changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Bombay Dyeing & Manufacturing Company Ltd changed from ₹ 1448 crore on March 2021 to ₹ 2680 crore on March 2025 . This represents a CAGR of 13.10% over 5 yearsThe Market Cap of Skybiotech Healthcare Limited changed from ₹ 31.33 crore on March 2025 to ₹ 31.33 crore on March 2025 . This represents a CAGR of 0.00% over 1 years The revenue of Bombay Dyeing & Manufacturing Company Ltd for the Mar '26 is ₹ 437.75 crore as compare to the Dec '25 revenue of ₹ 350.69 crore. This represent the growth of 24.83% The revenue of Skybiotech Healthcare Limited for the Mar '26 is ₹ 1.98 crore as compare to the Dec '25 revenue of ₹ 1.04 crore. This represent the growth of 90.38% The ebitda of Bombay Dyeing & Manufacturing Company Ltd for the Mar '26 is ₹ 40.26 crore as compare to the Dec '25 ebitda of ₹ -1.71 crore. This represent the decline of -2454% The ebitda of Skybiotech Healthcare Limited for the Mar '26 is ₹ -0.73 crore as compare to the Dec '25 ebitda of ₹ -0.36 crore. This represent the growth of 102.78% The net profit of Bombay Dyeing & Manufacturing Company Ltd changed from ₹ 15.54 crore to ₹ 21.04 crore over 8 quarters. This represents a CAGR of 16.36% The net profit of Skybiotech Healthcare Limited changed from ₹ 0.25 crore to ₹ -0.3 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Bombay Dyeing & Manufacturing Company Ltd changed from 0.84 % on March 2024 to 5.06 % on March 2025 . This represents a CAGR of 145.43% over 2 yearsThe Dividend Payout of Skybiotech Healthcare Limited changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Bombay Dyeing & Manufacturing Company Ltd

Bombay Dyeing and Manufacturing Company Limited, established by Nowrosjee Wadia on 23 August, 1879 is the flagship company of the Wadia Group, engaged primarily in the business of Real Estate Development, Polyester Staple Fibre and Retail.
Stylish linens, towels, home furnishings, leisure clothing, kids wear and a whole blissful range of other products are now available across 350+ exclusive Bombay Dyeing Retail or 2000+ Multi-brand stores.
The company's Bed, Bath & Coordinates retail business is operated under the Home & You brand. In real estate development business, the Company enjoys the benefits of two large contiguous land parcels with clear titles, giving it a significant advantage over other real estate players.
The two sites are strategically located and well connected with the commercial hub of Central Mumbai and equidistant from the commercial hubs of South Mumbai and Bandra-Kurla Complex.

About Skybiotech Healthcare Limited

Skybiotech Healthcare Limited was initially incorporated as Kapil Cotex Limited on October 14, 1983.
The Company has altered a change in name with due approval from the Registrar of Companies to Skybiotech Healthcare Limited in 2025. he Company is involved in Spinning, weaving and finishing of textiles. During the concerned year, it did not get any revenue from its main objects.
However, it gives consultancy & assistance in selling the goods of foreign clients & earned brokerage/consultancy income.
It also deals in shares & Securities, where it earned capital gains & dividend income. Company has acquired 72.52% stake in M/s.
Skybiotech Lifescience Private Limited, making it a subsidiary of the Company in 2024.

FAQs for the comparison of Bombay Dyeing & Manufacturing Company Ltd and Skybiotech Healthcare Limited

Which company has a larger market capitalization, Bombay Dyeing & Manufacturing Company Ltd or Skybiotech Healthcare Limited?

Market cap of Bombay Dyeing & Manufacturing Company Ltd is 2,715 Cr while Market cap of Skybiotech Healthcare Limited is 38 Cr

What are the key factors driving the stock performance of Bombay Dyeing & Manufacturing Company Ltd and Skybiotech Healthcare Limited?

The stock performance of Bombay Dyeing & Manufacturing Company Ltd and Skybiotech Healthcare Limited is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bombay Dyeing & Manufacturing Company Ltd and Skybiotech Healthcare Limited?

As of June 28, 2026, the Bombay Dyeing & Manufacturing Company Ltd stock price is INR ₹131.5. On the other hand, Skybiotech Healthcare Limited stock price is INR ₹199.95.

How do dividend payouts of Bombay Dyeing & Manufacturing Company Ltd and Skybiotech Healthcare Limited compare?

To compare the dividend payouts of Bombay Dyeing & Manufacturing Company Ltd and Skybiotech Healthcare Limited, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.